Literature DB >> 21029943

Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy.

Mun Yew Patrick Chan1, Serene Lim.   

Abstract

BACKGROUND: Some patients who are initially diagnosed with ductal carcinoma in situ (DCIS) by core biopsy eventually have their disease upstaged to invasive carcinoma on final excision, thus warranting some form of axillary staging. This study aimed to identify the predictors of invasive breast cancer in DCIS diagnosed by core biopsy, which could then help clinicians decide which cases of biopsy-diagnosed DCIS should undergo concurrent sentinel lymph node biopsy during excision.
METHODS: The records of 95 consecutive patients diagnosed with pure DCIS from 100 core biopsies from January 2005 to August 2007 were retrospectively reviewed. The clinical, radiological and pathological characteristics of these 100 cases were correlated with the presence of invasion or microinvasion on excision.
RESULTS: Factors that are associated with invasive or microinvasive foci on excisional histology are: size of target lesion on radiography ≥ 20 mm [odds ratio: 6.738 (1.050-43.236), p = 0.044] and ≤ 10 cores obtained [odds ratio: 22.343 (2.351-212.385), p = 0.007].
CONCLUSION: Underestimation of invasive breast cancer in core biopsy-diagnosed DCIS is related to the size of the lesion on radiography, as well as the number of cores obtained during biopsy.
Copyright © 2010 Asian Surgical Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21029943     DOI: 10.1016/S1015-9584(10)60013-9

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  12 in total

Review 1.  Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?

Authors:  Andrew Pieri; James Harvey; Nigel Bundred
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer.

Authors:  Mio Yoshikawa; Hisae Iinuma; Yasuko Umemoto; Takako Yanagisawa; Akiko Matsumoto; Hiromitsu Jinno
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

3.  Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.

Authors:  Rui Hou; Lars J Grimm; Maciej A Mazurowski; Jeffrey R Marks; Lorraine M King; Carlo C Maley; Thomas Lynch; Marja van Oirsouw; Keith Rogers; Nicholas Stone; Matthew Wallis; Jonas Teuwen; Jelle Wesseling; E Shelley Hwang; Joseph Y Lo
Journal:  Radiology       Date:  2022-01-04       Impact factor: 29.146

4.  Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.

Authors:  Jing Si; Benlong Yang; Rong Guo; Naisi Huang; Chenlian Quan; Linxiaoxi Ma; Bingqiu Xiu; Yun Cao; Yue Tang; Linxiao Shen; Jiajian Chen; Jiong Wu
Journal:  Cancer Biol Med       Date:  2019-05       Impact factor: 4.248

5.  Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy.

Authors:  Suzanne C E Diepstraten; Stephanie M W Y van de Ven; Ruud M Pijnappel; Petra H M Peeters; Maurice A A J van den Bosch; Helena M Verkooijen; Sjoerd G Elias
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

6.  Sentinel Lymph Node Biopsy Should Be Included with the Initial Surgery for High-Risk Ductal Carcinoma-In-Situ.

Authors:  Ern Yu Tan; Z W Joseph Lo; Chuan Han Ang; Christine Teo; Melanie D W Seah; Juliana J C Chen; Patrick M Y Chan
Journal:  Int Sch Res Notices       Date:  2014-10-29

7.  Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes.

Authors:  Milim Kim; Hyun Jeong Kim; Yul Ri Chung; Eunyoung Kang; Eun-Kyu Kim; Se Hyun Kim; Yu Jung Kim; Jee Hyun Kim; In Ah Kim; So Yeon Park
Journal:  J Breast Cancer       Date:  2018-06-20       Impact factor: 3.588

8.  The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients.

Authors:  Jianchun Kong; Xiaomin Liu; Xiaodan Zhang; Yu Zou
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

9.  Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.

Authors:  Kwan Ho Lee; Jeong Woo Han; Eun Young Kim; Ji Sup Yun; Yong Lai Park; Chan Heun Park
Journal:  BMC Cancer       Date:  2019-12-10       Impact factor: 4.430

10.  Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.

Authors:  Jing Si; Rong Guo; Naisi Huang; Bingqiu Xiu; Qi Zhang; Weiru Chi; Jiong Wu
Journal:  Cancer Med       Date:  2019-10-29       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.